VERSES AI, though a smaller company in the AI landscape with a market cap of $150M, stands as a credible and innovative contender, primarily due to its strategic partnerships and the expertise of its chief scientist. The following points elucidate why VERSES AI, despite its size, is a significant player in the AI field.
Contrary to existing antimicrobial coatings, which function by eliminating microorganisms upon contact over some adequate duration of time, the technology developed by FendX takes a preventative approach. Utilizing nanotechnology to develop film and spray protective coatings that prevent microbial adherence to surfaces, thereby minimizing the potential for transmission.
Contrary to existing antimicrobial coatings, which function by eliminating microorganisms upon contact over some adequate duration of time, the technology developed by FendX takes a preventative approach. Utilizing nanotechnology to develop film and spray protective coatings that prevent microbial adherence to surfaces, thereby minimizing the potential for transmission.
The report envisions encoding laws and legal principles into an understandable, machine-readable language, facilitating autonomous compliance by AI systems. It’s a critical step toward a safe, effective, and inclusive journey down the “Road to Autonomy,” aligning future AI systems not only with technical advancement but also with the best interests of humanity.
Investors looking for exposure to a potentially high-growth, innovative company in the nanotechnology market are invited to take a closer look at FendX Technologies Inc.. With its tight share structure, pioneering nanotechnology, and a seasoned team of industry professionals with extensive experience in bringing products to market in the healthcare industry, FendX is well-positioned to first penetrate the healthcare market and grow beyond it.
Investors looking for exposure to a potentially high-growth, innovative company in the nanotechnology market are invited to take a closer look at FendX Technologies Inc.. With its tight share structure, pioneering nanotechnology, and a seasoned team of industry professionals with extensive experience in bringing products to market in the healthcare industry, FendX is well-positioned to first penetrate the healthcare market and grow beyond it.
Friston is short listed for a Nobel Prize, is one of the most cited scientists in human history with over 260,000 academic citations, and invented all of the mathematics behind the fMRI scan. As one pundit put it, “what Einstein was to physics, Friston is to Intelligence.”
People are tired of being spied on and having their personal data bought and sold without their knowledge or consent.
This $400 billion data market is ripe for a revolution. Both consumer sentiment and legislation are signaling that changes to the current status quo will accelerate in the very near term.
Reklaim (TSXV: MYID, OTCQB: MYIDF) is the North American company at the center of the inevitable data privacy revolution.
People are tired of being spied on and having their personal data bought and sold without their knowledge or consent.
This $400 billion data market is ripe for a revolution. Both consumer sentiment and legislation are signaling that changes to the current status quo will accelerate in the very near term.
Reklaim (TSXV: MYID, OTCQB: MYIDF) is the North American company at the center of the inevitable data privacy revolution.
Netflix devoured Blockbuster’s market share by offering digital, streaming delivery of products that were previously only available via physical delivery. Hapbee is disrupting the marketplace for ingestible compounds in exactly the same way.
